Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stephanie Merhar, MD
Age
0–0
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Gestational age ≥ 35 weeks
Postnatal age ≤ 30 days
Birth weight ≥ 2000 grams
Clinical or electrographic seizures of any etiology requiring treatment with an antiepileptic medication (as per the judgment of the clinician caring for the patient)
Parental consent obtained
You may not be if
Infants with renal insufficiency indicated by serum creatinine \> 2.0 (as part of pre-screening, labs obtained as part of routine care will be reviewed. Infants who have not had a creatinine drawn will have one drawn as part of the study after consent is obtained. If the baby requires levetiracetam emergently before the results of the creatinine are back, the dose will still be given and levels will still be drawn as per the protocol.
Infants who have previously received levetiracetam
